Home › NDC Lookup › RxCUI directory › RxCUI 2205104

30 ACTUAT aclidinium bromide 0.4 MG/ACTUAT / formoterol fumarate 0.012 MG/ACTUAT Dry Powde... — RxCUI 2205104

RxNorm drug concept · Semantic branded drug
RxCUI 2205104 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2205104
Official name30 ACTUAT aclidinium bromide 0.4 MG/ACTUAT / formoterol fumarate 0.012 MG/ACTUAT Dry Powder Inhaler [Duaklir]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDuaklir Pressair 400/12 ( aclidinium bromide 400 MCG/ formoterol fumarate 12 MCG ) per ACTUAT Dry Powder Inhaler, 30 Actuations; Duaklir Pressair 400/12 MCG/INHAL Dry Powder Inhaler, 30 Actuations
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Formoterol Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Formoterol helps keep your airways open over the course of the day. It relaxes the muscles around your airways so air can flow in and out more easily. It's a maintenance medication...
  • What exactly is formoterol supposed to do for my COPD?
  • No — formoterol is not a rescue inhaler and should not be used for sudden breathlessness or a COPD flare-up. For those moments, you need a separate short-acting inhaler (like albut...
  • Can I use it when I'm suddenly struggling to breathe?
📖 Read our full Formoterol Oral Inhalation guide →

🕸️ Concept Web — How 30 ACTUAT aclidinium bromide 0.4 MG/ACTUAT / for... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 30 ACTUAT aclidinium bromide 0.4 MG/ACTUAT / formoterol fumarate 0.012 MG/ACTUAT Dry Powder Inhaler [Duaklir] RxCUI 2205104

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Aclidinium 1303098
    • Formoterol 25255
    • Aclidinium / formoterol 2205093
    • Aclidinium bromide 1303097
    • Formoterol fumarate 236216
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Duaklir 2205095
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aclidinium / formoterol Dry Powder Inhaler 2205092
    • Aclidinium bromide / formoterol fumarate Dry Powder Inhaler 2647308
    • Aclidinium / formoterol Inhalant Product 2205091
    • Aclidinium bromide / formoterol fumarate Inhalant Product 2659606
    • Aclidinium / formoterol Dry Powder Inhaler [Duaklir] 2205097
    • Aclidinium bromide / formoterol fumarate Dry Powder Inhaler [Duaklir] 2654296
    • Duaklir Inhalant Product 2205098
    • Dry Powder Inhaler 744995
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Aclidinium bromide 0.4 MG/ACTUAT / formoterol fumarate 0.012 MG/ACTUAT [Duaklir] SBDC · 2205096
  • Aclidinium / formoterol Dry Powder Inhaler [Duaklir] SBDF · 2205097
  • Aclidinium bromide / formoterol fumarate Dry Powder Inhaler [Duaklir] SBDFP · 2654296
  • Duaklir Inhalant Product SBDG · 2205098
  • Duaklir BN · 2205095

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2205104 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70515-0001-01 1 POUCH in 1 CARTON (70515-001-01) / 1 INHALER in 1 POUCH /... DUAKLIR PRESSAIR Covis Pharma US, Inc 2019-03-29
70515-0001-03 1 POUCH in 1 CARTON (70515-001-03) / 1 INHALER in 1 POUCH /... DUAKLIR PRESSAIR Covis Pharma US, Inc 2019-03-29
Observed labelers: Covis Pharma US, Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.